METHOTREXATE SODIUM PRESERVATIVE FREE
METHOTREXATE SODIUM
Approval overview METHOTREXATE SODIUM PRESERVATIVE FREE is listed in Drugs@FDA under application 203407 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient METHOTREXATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 250MG BASE/10ML (EQ 25MG BASE/ML) Sponsor SAGENT PHARMS INC Submission history Latest submission status date: 2021-08-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview METHOTREXATE SODIUM PRESERVATIVE FREE is listed in Drugs@FDA under application 203407 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient METHOTREXATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 250MG BASE/10ML (EQ 25MG BASE/ML) Sponsor SAGENT PHARMS INC Submission history Latest submission status date: 2021-08-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.